معرفی
Rimma Axelsson is a Professor of Nuclear Medicine and Senior Physician at Karolinska Institutet, affiliated with the Department of Molecular Medicine and Surgery. She holds leadership roles as founder of the Theranostics Trial Center and program leader for the Theranostics Trial Alliance Sweden. Her expertise spans nuclear medicine, radiology, and molecular imaging.
Education: MD (1995), PhD (2000, Karolinska Institutet), Specialist in Nuclear Medicine (1997) and Radiology (2000), Docent (2006), and Adjunct Professor (2012–2022).
Research focuses on theranostics, PET imaging for cancer therapy selection, and molecular diagnostics. Key areas include HER2 targeting, PSMA imaging, and FAPI-46 applications. She leads grants on TROP-2 targeted radiopharmaceuticals and imaging advancements in prostate cancer staging.
Publications emphasize precision medicine, radiopharmaceutical development, and oncologic imaging. Her work bridges clinical practice and research, aiming to personalize cancer treatment through molecular imaging.
